Perrigo to sell generic drugs business to Altaris Capital for $1.55 bln

  • 3/1/2021
  • 00:00
  • 6
  • 0
  • 0
news-picture

March 1 (Reuters) - Perrigo Company Plc said on Monday it would sell its generic drugs business to private equity firm Altaris Capital Partners for a total consideration of $1.55 billion. (Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila)

مشاركة :